Troponin I to T Ratio Distinguishes Acute Necrosis From Chronic Injury

A multicohort study finds the troponin ratio identifies lethal cell death and improves differentiation of type 1 and 2 myocardial infarction.

For Doctors in a Hurry

Researchers investigated whether the ratio of cardiac troponin I to T distinguishes acute necrotic injury from chronic or non-necrotic myocardial damage.
This multicohort study analyzed 9,704 individuals across three prospective clinical trials and four experimental cardiomyocyte models simulating various injury severities.
The cardiac troponin ratio was 2.06 in acute disease, significantly higher than the 0.66 observed in chronic cardiac conditions.
The authors concluded that cardiac troponin I and T are not interchangeable because their ratio reflects the specific injury type.
Using this ratio improved discrimination between type 1 and type 2 myocardial infarction, reaching an area under the curve of 0.73.

Redefining the Interchangeability of Cardiac Troponins

In clinical practice, cardiac troponin I and cardiac troponin T are widely treated as interchangeable biomarkers for myocardial injury, used in conditions ranging from acute coronary syndromes to traumatic brain injury [1, 2]. This convention, however, presents a diagnostic challenge, as clinicians frequently encounter elevated troponin levels in settings where acute necrosis is not the primary mechanism, such as chronic heart failure, perioperative stress, and severe viral infections [3, 4, 5]. For instance, a study of 187 patients with COVID-19 found that myocardial injury occurred in 27.8 percent of cases, and patients with both underlying cardiovascular disease and elevated troponin T had a mortality rate of 69.44 percent [6]. Current guidelines advise searching for noncoronary causes when symptoms and biomarker elevations are discordant [7]. A recent study now challenges the assumption of interchangeability, investigating whether the ratio between these two proteins can offer a more nuanced signal that reflects the specific type of cellular damage.

Quantifying the Ratio Across Disease States

To determine if the relationship between cardiac troponin I (cTnI) and cardiac troponin T (cTnT) holds diagnostic value, researchers analyzed data from a large, multicohort study of 9,704 individuals. Participants were stratified into three groups based on centrally adjudicated diagnoses: no known cardiac disease, chronic cardiac disease, or acute cardiac disease. Using high-sensitivity assays (Architect for hs-cTnI and Elecsys for hs-cTnT), the study employed regression models to assess how the cTnI/cTnT ratio correlated with these distinct clinical states. This approach was designed to test whether the ratio could serve as a biologically meaningful indicator of both the type and severity of myocardial injury. The analysis revealed a stark difference in the ratio across the diagnostic categories. The cTnI/cTnT ratio was highest in patients with acute cardiac disease, at 2.06 (95% CI: 1.89-2.26). This value was approximately four times greater than the ratio in patients with chronic cardiac disease (0.66; 95% CI: 0.60-0.72) and those with no known cardiac disease (0.50; 95% CI: 0.43-0.59). These findings suggest that the relative concentration of the two troponins provides a distinct biological signal, differentiating the acute necrotic processes of an event like a myocardial infarction from the more chronic or non-necrotic myocardial stress seen in other conditions.

Mechanistic Evidence From Cardiomyocyte Models

To understand the cellular basis for the divergent troponin ratios observed in patients, the investigators turned to experimental models. While previous pilot studies had hinted at this phenomenon, the underlying mechanism was unclear. The research team used four distinct experimental cardiomyocyte models to simulate and compare the effects of mild, nonlethal injury against severe, lethal injury. This in vitro approach allowed for precise measurement of troponin release patterns under controlled conditions, directly linking the degree of cellular damage to the specific biomarker profile. The experimental results provided a clear physiological explanation for the clinical findings. In models simulating mild, nonlethal injury, cardiomyocyte stress resulted in a cTnT-dominant release, yielding a cTnI/cTnT ratio of approximately 0.5. Conversely, models of lethal injury triggered a cTnI-dominant release, with a cTnI/cTnT ratio greater than 1. This suggests that the structural degradation accompanying irreversible cell death preferentially liberates cTnI, whereas less severe, non-necrotic stress favors the release of cTnT. These experimental observations were robust, as they were validated using alternative high-sensitivity cTnI assays and external patient cohorts, confirming the signal was not an artifact of a single measurement technique. By pairing large-scale clinical data with these controlled cellular experiments, the study establishes that the cTnI/cTnT ratio reliably distinguishes acute necrotic injury from chronic or non-necrotic myocardial stress.

Improving Differentiation of Myocardial Infarction Types

A persistent challenge in acute care is distinguishing type 1 myocardial infarction (AMI), caused by atherothrombotic plaque rupture, from type 2 AMI, which stems from an oxygen supply-demand mismatch. The study investigated whether the cTnI/cTnT ratio could help clarify the underlying pathophysiology. The findings show that incorporating the cTnI/cTnT ratio into a predictive model alongside individual troponin concentrations improved the discrimination between type 1 and type 2 AMI. This diagnostic utility was quantified using the area under the receiver operating characteristic curve (AUC), a measure of a test's ability to distinguish between two conditions. The statistical model that included only individual troponin levels had an AUC of 0.70 (95% CI: 0.67-0.73) for differentiating AMI types. When the cTnI/cTnT ratio was added, the AUC increased to 0.73 (95% CI: 0.70-0.76). This improvement was statistically significant (P < 0.01), demonstrating that the ratio provides independent diagnostic information beyond the absolute value of either biomarker alone. For clinicians, this suggests the ratio could become a valuable tool to more accurately identify patients with acute necrotic injury versus those with secondary myocardial stress, potentially refining triage and treatment strategies.

Study Info

The cTnI/cTnT Ratio in Myocardial Injury

Tobias Zimmermann, Luca Koechlin, Joan Walter, Dorien M. Kimenai, et al.

Journal Journal of the American College of Cardiology

Published February 25, 2026